Paul Estrem serves as Executive at MELINTA THERAPEUTICS, INC. /NEW/, where they oversee executive responsibilities. Since joining the company, Paul Estrem has executed 1 insider transactions totaling $50.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on May 29, 2018 involved purchasing 10,000 shares valued at $50.0K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| May 29, 2018 | MLNT | $50.0K | Purchase | 10,000 | $5.00 | Discretionary |
Paul Estrem currently holds 10,000 shares of MELINTA THERAPEUTICS, INC. /NEW/ (MLNT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Paul Estrem has been a net buyer of MLNT stock. They have purchased $50.0K and sold $0 worth of shares.
Paul Estrem's most recent insider trade was on May 29, 2018, when they purchased 10,000 shares at $5.00 per share.
Get notified when new Form 4 filings are submitted